Blood test could spot lung transplant trouble early
NCT ID NCT06679257
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing a new blood test to quickly identify damage or infection in lung transplant patients. Researchers will take blood samples at regular times and when problems occur, then compare the results to standard tests. The goal is to make diagnosis faster and easier, which could help patients live longer after a lung transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cell-free DNA blood test
What this could lead to
If successful, this blood test could help doctors quickly identify lung transplant damage or infection, potentially improving survival and reducing the need for invasive biopsies.
What could go wrong
This is an early observational study with 146 participants. The test may not be accurate enough to replace current methods, and results may not apply to all transplant patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT FAILURE AND REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sahlgrenska University hospital
RECRUITINGGothenburg, Västra Götaland County, 413 45, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••